Recent Finacing
Recent Raise
Cardialen develops an implantable low-energy atrial cardioverter using sequenced low-voltage pulses (UPT) to convert atrial fibrillation with reduced tissue damage; clinical HQ in St. Louis, production in St. Paul.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at CardiaLen.
